Literature DB >> 21350822

Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells.

Shuichi Ozono1, Hiroko Inada2, Shin-Ichiro Nakagawa2, Koichiro Ueda2, Hideki Matsumura3, Seiji Kojima3, Hiroshi Koga4, Takashi Hashimoto4, Koichi Oshima5, Toyojiro Matsuishi2.   

Abstract

We present a 1-year-old boy who developed a cutaneous lesion on the trunk and hepatosplenomegaly. Laboratory examination showed leukocytosis with peripheral blasts, atypical monocytosis, anemia, hyper IgG, and a mild elevation of C-reactive protein. Clinical features and skin biopsy findings matched the diagnostic criteria of both juvenile myelomonocytic leukemia (JMML) and Langerhans cell histiocytosis (LCH). Histopathology revealed atypical mononuclear cells that had infiltrated around vessels throughout the dermis in a skin biopsy specimen. These cells were CD1a (+), S-100 (+), CD68 (+), CD207 (-), lysozyme (+), and myeloperoxidase (-). The diagnosis of JMML was confirmed by detection of spontaneous colony formation and granulocyte-macrophage colony-stimulating factor hypersensitivity in vitro, and a somatic NRAS point mutation. Transplantation of bone marrow from an HLA-matched unrelated donor was performed, and the marrow was successfully engrafted. The cutaneous lesion and hepatosplenomegaly were improved at the time of discharge. It is often difficult to distinguish between JMML and LCH-like infiltrates by assessing clinical and light microscopic features of various cutaneous lesions. In the current case, molecular biological analysis enabled us to develop a precise diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 21350822     DOI: 10.1007/s12185-011-0787-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Differentiating juvenile myelomonocytic leukemia from infectious disease.

Authors:  D Pinkel
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

Review 2.  Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.

Authors:  B E Favara; A C Feller; M Pauli; E S Jaffe; L M Weiss; M Arico; P Bucsky; R M Egeler; G Elinder; H Gadner; M Gresik; J I Henter; S Imashuku; G Janka-Schaub; R Jaffe; S Ladisch; C Nezelof; J Pritchard
Journal:  Med Pediatr Oncol       Date:  1997-09

3.  The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society.

Authors:  R M Egeler; J P Neglia; M Aricò; B E Favara; A Heitger; M E Nesbit; H S Nicholson
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

4.  Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood.

Authors:  F Locatelli; C Niemeyer; E Angelucci; C Bender-Götze; S Burdach; W Ebell; W Friedrich; H Hasle; J Hermann; N Jacobsen; T Klingebiel; B Kremens; G Mann; A Pession; C Peters; H J Schmid; J Stary; M Suttorp; C Uderzo; E T van't Veer-Korthof; J Vossen; M Zecca; M Zimmermann
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

Review 5.  Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors:  C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

6.  Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders.

Authors:  Kudakwashe Chikwava; Ronald Jaffe
Journal:  Pediatr Dev Pathol       Date:  2004-11-08

7.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

8.  Clinical spectrum of cutaneous Langerhans' cell histiocytosis mimicking various diseases.

Authors:  Kerstin Querings; Hans Starz; Bernd-Rüdiger Balda
Journal:  Acta Derm Venereol       Date:  2006       Impact factor: 4.437

Review 9.  Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells.

Authors:  Jenny Valladeau; Colette Dezutter-Dambuyant; Sem Saeland
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 10.  Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.

Authors:  Ayami Yoshimi; Seiji Kojima; Naoto Hirano
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

View more
  4 in total

Review 1.  Histiocytic neoplasms in the era of personalized genomic medicine.

Authors:  Benjamin H Durham; Eli L Diamond; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

2.  Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia.

Authors:  Stefan P Tarnawsky; Michihiro Kobayashi; Rebecca J Chan; Mervin C Yoder
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

Review 3.  Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms.

Authors:  Neval Ozkaya; Ahmet Dogan; Omar Abdel-Wahab
Journal:  Hematol Oncol Clin North Am       Date:  2017-05-17       Impact factor: 3.722

Review 4.  MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

Authors:  Rikhia Chakraborty; Omar Abdel-Wahab; Benjamin H Durham
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.